The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Infinity Pharmaceuticals Inc

Nasdaq: INFI
Last

(U.S.) $1.98

Today's change+0.02 +1.02%
Updated April 25 3:08 PM EDT. Delayed by at least 15 minutes.
 

Infinity Pharmaceuticals Inc

Nasdaq: INFI
Last

(U.S.) $1.98

Today's change+0.02 +1.02%
Updated April 25 3:08 PM EDT. Delayed by at least 15 minutes.

Infinity Pharmaceuticals Inc up (U.S.)$0.02

Infinity Pharmaceuticals Inc is up today by (U.S.)$0.02 or 1.02% to (U.S.)$1.98. Shares have lost 1.00% over the last five days, but have gained 46.67% over the last year to date. This security has underperformed the S&P 500 by 83.72% during the last year.

Key company metrics

  • Open(U.S.) $1.98
  • Previous close(U.S.) $1.96
  • High(U.S.) $1.99
  • Low(U.S.) $1.93
  • Bid / Ask(U.S.) $1.98 / (U.S.) $1.99
  • YTD % change+46.67%
  • Volume301,257
  • Average volume (10-day)1,363,397
  • Average volume (1-month)1,075,280
  • Average volume (3-month)1,144,012
  • 52-week range(U.S.) $0.84 to (U.S.) $6.63
  • Beta2.42
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.60
Updated April 25 3:08 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.29%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue0099
Total other revenue--------
Total revenue0099
Gross profit--------
Total cost of revenue--------
Total operating expense2320-4450
Selling / general / administrative971611
Research & development15135339
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-23-2053-41
Interest income (expense), net non-operating0000
Gain (loss) on sale of assets--------
Other--------
Income before tax-23-1953-41
Income after tax-23-1953-41
Income tax, total00----
Net income-23-1953-41
Total adjustments to net income--------
Net income before extra. items-23-1953-41
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-23-1953-41
Inc. avail. to common incl. extra. items-23-1953-41
Diluted net income-23-1953-41
Dilution adjustment----0--
Diluted weighted average shares50504949
Diluted EPS excluding extraordinary itemsvalue per share-0.46-0.391.07-0.82
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share-0.46-0.391.07-0.82